Duchene's Muscular Dystrophy
Conditions
Keywords
Duchene's muscular Dystrophy, Pulmonary Functions, Pediatrics, motor performance
Brief summary
25 boys, ages ranging from 6 to 16 years, diagnosed with Duchene's muscular Dystrophy (DMD) will participated in the study. They will be selected from the Pediatric Rehabilitation Center of Deraya University's outpatient clinic in El-Minia district, Minia-Egypt. The outcome will be assessed motor performance will be assed by Bruininks-Oseretsky Test of Motor Proficiency Second Edition (BOT™-2) : balance, running speed and agility, bilateral coordination and strength and by Blue Cherry; Geratherm Respiratory. It is used to measure vital capacity (VC), forced expired volume in one second (FEV1), FEV1/FVC, FEV1/VC, and peak expiratory flow (PEF) to provide objective information for monitoring lung health.
Interventions
None listed
Sponsors
Cairo University
Study design
Observational model
OTHER
Time perspective
CROSS_SECTIONAL
Eligibility
Sex/Gender
ALL
Age
6 Years to 16 Years
Healthy volunteers
No
Inclusion criteria
* the diagnosis is Duchene's muscular Dystrophy only not other types, * ambulated with or without assistance, * oriented and endurance enough to understand orders to perform ventilation on the Blue Cherry; Geratherm Respiratory device.
Exclusion criteria
* any cognitive or neurological condition (other than Duchene's muscular Dystrophy), * history of previous surgical operations that can affect pulmonary functions, and structural scoliosis
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| motor performance | measured for one time | motor performance will be assessed by Bruininks-Oseretsky Test of Motor Proficiency Second Edition (BOT™-2) |
| respiratory function | measured for only one time | respiratory function by Blue Cherry; Geratherm Respiratory. It is used to measure respiratory function to provide objective information for monitoring lung health. |
Contacts
Primary ContactAhmed Salman
Outcome results
None listed